InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,288.80
(
-0.62%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
84.99
(
-0.02%
)
Bitcoin
64,612.21
(
-0.32%
)
Post# of 4972568
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

stock1ace1

Send PM Follow Ignore
Followers 276
Posts 36562
Boards Moderated 2
Alias Born 04/05/2012

stock1ace1

Re: glenn1919 post# 4970055

Tuesday, 05/28/2024 9:33:00 AM

Tuesday, May 28, 2024 9:33:00 AM

Post# of 4972568
Cing .79 pending news licensing partnership news & NDA for there phase 3 adhd drug


-> 3 Million Float / 6 Mill o/s

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

“”We also believe this communication provides additional go-to-market momentum as we continue to meet with potential partners for the outlicensing of CTx-1301 in the United States and abroad.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up